Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Diazepam Nasal Spray in Healthy Volunteers
NCT02663999Phase 1Completed
- Sponsor
- Acorda Therapeutics
- Start
- Jan 2016
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of diazepam nasal spray in seizure cluster (2 arms), sponsored by Acorda Therapeutics. Primary endpoints: Maximum measured plasma concentration, Area under the concentration curve from time 0 to 24 hours and 2 more. Started Jan 2016; status: completed.
02
Drugs
diazepam nasal spray
03
Conditions
seizure cluster
Beyond the preview
Go deeper on NCT02663999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02663999.